Cargando…

Incremental predictive value of the combined use of the neutrophil-to-lymphocyte ratio and systolic blood pressure difference after successful drug-eluting stent implantation

BACKGROUND: Previous work has highlighted the importance of the neutrophil-to-lymphocyte ratio (NLR) and the difference in the ward-to-catheterization laboratory systolic blood pressure (ΔSBP) in prognostic stratification after acute coronary syndrome. However, there is paucity of data regarding the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yong Hoon, Her, Ae-Young, Garg, Scot, Shin, Eun-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2023
Materias:	Clinical Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987556/ https://www.ncbi.nlm.nih.gov/pubmed/33438177 http://dx.doi.org/10.5603/CJ.a2021.0004

Ejemplares similares

Extremely Late In-Stent Thrombosis 12 Years After Implantation of a Drug-Eluting Stent
por: Sleiman, Elsa, et al.
Publicado: (2020)

Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent
por: Cho, Kyoung Im, et al.
Publicado: (2015)

Angiotensin converting enzyme inhibitors versus angiotensin II type 1 receptor blockers in patients with acute myocardial infarction and prediabetes after successful implantation of newer-generation drug-eluting stents
por: Kim, Yong Hoon, et al.
Publicado: (2023)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
por: Fang, Chih-Yuan, et al.
Publicado: (2018)

Real-World Clinical Outcomes of Indigenous Biodegradable Polymer Drug-Eluting Stents
por: Kumar, Basant, et al.
Publicado: (2021)

A Comparison of Peri-Procedural Myocardial Infarction between Paclitaxel-Coated Balloon and Drug-Eluting Stent on De Novo Coronary Lesions
por: Her, Ae-Young, et al.
Publicado: (2017)

Biodegradable polymer-coated thin strut sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population
por: Gasior, Pawel, et al.
Publicado: (2021)

The Value of Neutrophil-to-Lymphocyte Ratio and Epicardial Adipose Tissue Thickness in Heart Failure With Preserved Ejection Fraction
por: Colluoglu, Tugce, et al.
Publicado: (2023)

Drug-Eluting Stents: Their Preventative/Prophylactic Role Against Gemcitabine Induced Acute Coronary Syndrome
por: Hamdan, Jaafar A, et al.
Publicado: (2021)

Multianalysis with optical coherence tomography and vasomotion in everolimus-eluting stents and everolimus-eluting biovascular scaffolds: the MOVES trial
por: Arroyo, Diego A, et al.
Publicado: (2018)

Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry
por: Jain, Ajay K, et al.
Publicado: (2010)

Assessment of anti-dislodgment capability for contemporary drug eluting stents
por: Ye, Yicong, et al.
Publicado: (2021)

Association of Inter-Arm Systolic Blood Pressure Difference with Coronary Atherosclerotic Disease Burden Using Calcium Scoring
por: Her, Ae-Young, et al.
Publicado: (2017)

Identifying the Incidence, Predictors, Outcomes, and Prevention of Stent Thrombosis (ST) in Post-percutaneous Coronary Revascularization Patients With Drug-Eluting Stents (DES): A Systematic Review
por: Sohail, Mehvish, et al.
Publicado: (2023)

Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: Results from the Korea Acute Myocardial infarction Registry (KAMIR)
por: Kim, Yongcheol, et al.
Publicado: (2019)

Predictive value of neutrophil-to-lymphocyte ratio on drug eluting stent restenosis in patients with type 2 diabetes mellitus
por: Wang, Zhi-Chao, et al.
Publicado: (2020)

“Burying” covered coronary stents under drug-eluting stents: A novel approach to ensure long-term stent patency
por: Bossard, Matthias, et al.
Publicado: (2023)

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010)

Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future
por: Xiang, Kun, et al.
Publicado: (2021)

Adverse Events in Primary Percutaneous Coronary Angioplasty With Drug-Eluting Stents Compared With Drug-Coated Balloons: A Retrospective Outlook
por: Sharif Khan, Hamid, et al.
Publicado: (2020)

Open-labeled randomized controlled trial to evaluate the 1-year clinical outcomes of polymer-free sirolimus-eluting coronary stents as compared with biodegradable polymer-based sirolimus-eluting coronary stents
por: Viswanathan, Sunitha, et al.
Publicado: (2018)

Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry
por: Shin, Eun-Seok, et al.
Publicado: (2023)

COVID-19 Infection Complicated by a Complete Occlusion of the Left Circumflex Artery With Acute Restenosis After Drug-Eluting Stent Placement
por: Zaher, Nathan, et al.
Publicado: (2020)

Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stents: Patient-Level Pooled Analysis From Two Indian Registries
por: Babu Pothineni, Ramesh, et al.
Publicado: (2023)

Prognostic Utility of Neutrophil-to-Lymphocyte Ratio on Adverse Clinical Outcomes in Patients with Severe Calcific Aortic Stenosis
por: Cho, Kyoung Im, et al.
Publicado: (2016)

Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography
por: Chen, B X, et al.
Publicado: (2008)

Randomised trial of the comparison of drug-eluting stents in patients with diabetes: OCT DES trial
por: Hamshere, Stephen, et al.
Publicado: (2018)

Polymer-free sirolimus-eluting stents in a large-scale all-comers population
por: Krackhardt, Florian, et al.
Publicado: (2017)

Tricuspid Annular Systolic Velocity to Left Ventricular Outflow Velocity Time Integral Ratio: Proof of Concept Utility Analysis
por: López-Candales, Angel, et al.
Publicado: (2021)

Recanalization of in-stent chronic total occlusion using intravascular lithotripsy and Firehawk(®) rapamycin target eluting coronary stents: A case report
por: Patrascu, Alexandru, et al.
Publicado: (2021)

Efficacy and safety of drug-eluting stents in elderly patients: A meta-analysis of randomized trials
por: Bae, SungA, et al.
Publicado: (2021)

Platelet-to-Lymphocyte Ratio as an Independent Factor Associated With Atrial Tachyarrhythmia
por: Chen, Cheng, et al.
Publicado: (2023)

Neutrophil-to-lymphocyte ratio predicts heart failure readmissions and outcomes in patients undergoing transcatheter aortic valve replacement
por: Khalil, Charl, et al.
Publicado: (2018)

In-stent restenosis due to delayed healing of abluminal bioresorbable polymer everolimus-eluting stent: insight from histopathological evaluation with directional coronary atherectomy
por: Yamamoto, Hiroyuki, et al.
Publicado: (2021)

Thyrotoxicosis-Induced Cardiomyopathy With Systolic Dysfunction
por: Khalil, Yusuf, et al.
Publicado: (2023)

Effects of Everolimus-Eluting Stents on the Left Ventricular Systolic and Diastolic Functions
por: Parsaee, Mohammad Sadegh, et al.
Publicado: (2015)

Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis
por: Monjur, Mohammad Riashad, et al.
Publicado: (2020)

Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold
por: Madanchi, Mehdi, et al.
Publicado: (2021)

Platelet-to-lymphocyte and Neutrophil-to-lymphocyte Ratios Predict Target Vessel Restenosis after Infrainguinal Angioplasty with Stent Implantation
por: Lee, Silvia, et al.
Publicado: (2020)

Long-term clinical outcome between beta-blocker with ACEI or ARB in patients with NSTEMI who underwent PCI with drug-eluting stents
por: Kim, Yong Hoon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aoql7ojo7pc9adgp87eqb7e7ei